Brazil To Fix Regulatory Reliance Shortfalls & Speed Up Approvals

 
• By Francesca Bruce
  
Pharmaceutical companies have told Brazil's medicines regulator that they see little benefit in approval pathways that use regulatory reliance processes. (Shutterstock)

More from Market Access

More from Latin America